Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-10-18
1990-08-28
Lipovsky, Joseph A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514821, A61K 3144
Patent
active
049525867
ABSTRACT:
A composition is provided which includes a balanced combination of an edrophonium component and an atropine component. A preferred embodiment has 0.5 mg of edrophonium chloride and 8 micrograms of atropine sulfate, with respect to patient weight. The inventive composition is useful to antagonize nondepolarizing blockade during medical treatment when muscle relaxation is no longer necessary, provides extremely rapid onset of action and results in minimal heart rate changes.
REFERENCES:
L. Gyermek, Int. J. Clin. Pharmacol. 15 (1977), 356-362 (No. 8).
Morris, et al., Anesthesiology, vol. 54, No. 5, pp. 399-402 (May 1981).
Kopman, Anesthesiology, vol. 51, No. 2, pp. 139-142 (Aug. 1979).
Bevan, Anesthesia, vol. 34, pp. 614-619 (1979).
Azar, et al., Anesthesia and Analgesia, vol. 61, No. 2, pp. 167-168 (Feb. 1982).
Samra, et al., Anesthesiology, vol. 57, No. 3, p. A287 (Sep. 1982).
Foldes, et al., Anesthesiology, vol. 55, No. 3, p. A201 (Sep. 1981).
Cronnelly, et al., Br. J. Anaesth., vol. 54, pp. 183-194 (1982).
Ferguson, et al., Anesthesiology, vol. 53, No. 5, pp. 390-394 (Nov. 1980).
Katz, Anesthesiology, vol. 28, No. 2, pp. 327-336 (1967).
Remington's Pharmaceutical Sciences 16th ed., pp. 838-840, 850-853 (1980).
A. R. Hunter, "Tensilon: A New Anti-Curare Agent", British Journal of Anaesthesia, 24: 175-186 (1952).
Cronnelly Roy
Miller Ronald Dean
Morris Robert B.
Lipovsky Joseph A.
The Regents of the University of California
LandOfFree
Edrophonium-atropine composition and therapeutic uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Edrophonium-atropine composition and therapeutic uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Edrophonium-atropine composition and therapeutic uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1590052